PA Medicaid dropped GLP-1 obesity coverage in 2026
The thing that's so important about it is that it's going to be less expensive
In Part 2, we examined how incretin-based treatments for obesity and diabetes could reshape future patterns of morbidity and mortality
Renal Impairment: In patients treated with GLP-1 receptor agonists, including Saxenda , there have been reports of acute renal failure and worsening of chronic renal failure, usually in association with nausea, vomiting, diarrhea, or dehydration, which may sometimes require hemodialysis
These patches are marketed to sound like legitimate GLP-1 treatments, but they dont contain the actual drug ingredients or have clinical evidence to back them up, says Dr
Room temperature or slightly warm fluids often sit better than very cold ones when youre nauseated